D3KDM3 (D3KDM3_SARS) SARS coronavirus HKU-39849
ORF1ab polyprotein UniProtKBInterProInteractive Modelling
7073 aa; Sequence (Fasta) ;
13 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
129 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of the nsp16 nsp10 SARS coronavirus complex |
Heteromer P0C6X7; | 3×NA; 5×CL; 1×SAH; 1×MG; 2×ZN; | ||||
Assess | ||||||
Crystal structure of the nsp16 nsp10 SARS coronavirus complex |
Heteromer P0C6X7; | 2×CL; 1×SAH; 2×NA; 1×MG; 2×ZN; | ||||
Assess | ||||||
Crystal structure of the nsp16 nsp10 SARS coronavirus complex |
Heteromer P0C6X7; | 1×NA; 5×CL; 1×SFG; 1×MG; 2×ZN; | ||||
Assess | ||||||
SARS-CoV nsp16-nsp10 complexed with N7-GTP |
Heteromer P0C6X7; | 2×PEG; 1×SRC; 1×NA; 2×ZN; | ||||
Assess | ||||||
Crystal structure of the SARS coronavirus nsp14-nsp10 complex with functional ligand SAM |
Heteromer P0C6X7; | 5×ZN; 1×MG; 1×SAM; | ||||
Assess | ||||||
Crystal structure of the SARS coronavirus nsp14-nsp10 complex with functional ligands SAH and GpppA |
Heteromer P0C6X7; | 5×ZN; 1×MG; 1×SAH; 1×G3A; | ||||
Assess | ||||||
Crystal structure of the SARS coronavirus nsp14-nsp10 complex |
Heteromer P0C6X7; | 5×ZN; 1×MG; | ||||
Assess | ||||||
SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors |
Heteromer P0C6U8; P0C6X7; | 2×ZN; | ||||
Assess | ||||||
SARS-Coronavirus NSP12 bound to NSP8 co-factor |
Heteromer P0C6U8; P0C6X7; | 2×ZN; | ||||
Assess | ||||||
Crystal structure of SARS-CoV papain-like protease in complex with C-terminal domain mouse ISG15 |
Heteromer P0C6X7; Q64339; | 1×ZN; | ||||
Assess | ||||||
Crystal structure of SARS-CoV papain-like protease in complex with the C-terminal domain of human I… |
Heteromer P05161; P0C6X7; | 1×ZN; 1×SO4; | ||||
Assess | ||||||
Crystal structure of SARS-CoV papain-like protease PLpro in complex with ubiquitin aldehyde |
Heteromer P0C6X7; P0CG48; | 1×ZN; | ||||
Assess | ||||||
Structure of SARS PLpro bound to a Lys48-linked di-ubiquitin activity based probe |
Heteromer P0C6X7; P0CG47; P0CG48; | 1×ACT; 1×NI; | ||||
Assess | ||||||
Crystal structure of SARS-CoV main protease H41A mutant in complex with an N-terminal substrate |
Heteromer P0C6X7; | |||||
Assess | ||||||
Crystal structure of nsp10/nsp16 complex of SARS coronavirus |
Heteromer P0C6U8; P0C6X7; | 1×SAM; 2×ZN; | ||||
Assess | ||||||
Crystal structure of SARS-CoV super complex of non-structural proteins: the hexadecamer |
Heteromer P0C6X7; | 10×GOL; 2×SO4; | ||||
Assess | ||||||
SARS-CoV nsp10/nsp14 dynamic complex |
Heteromer P0C6X7; Q1T6X8; | 5×ZN; 2×PEG; | ||||
Assess | ||||||
C-terminal domain of SARS-CoV nsp8 complex with nsp7 |
Heteromer P0C6U8; P0C6X7; | |||||
Assess | ||||||
Complex structure of PEDV 3CLpro mutant (C144A) with a peptide substrate. |
Heteromer P0C6X7; R4JK63; | |||||
Assess | ||||||
The octameric SARS-CoV main protease | homo-8-mer | |||||
Assess | ||||||
Crystal Structure of Nsp 15 from SARS | homo-6-mer | |||||
Assess | ||||||
Crystal structure of Nsp15-H234A mutant- Hexamer in asymmetric unit | homo-6-mer | |||||
Assess | ||||||
Structure of an N-Terminal Truncated Form of Nendou (NSP15) From SARS-CORONAVIRUS | homo-4-mer | |||||
Assess | ||||||
Crystal structure of MS8104 | homo-2-mer | |||||
Assess | ||||||
Structure of SARS-CoV main protease bound to potent broad-spectrum non-covalent inhibitor X77 | homo-2-mer | 2×DMS; 2×X77; 4×MES; | ||||
Assess | ||||||
Structure of SARS main protease bound to inhibitor X47 | homo-2-mer | 4×MES; 2×X47; 2×DMS; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with an alpha, beta-unsaturated ethyl… | homo-2-mer | 2×G85; | ||||
Assess | ||||||
Structure of SARS-3CL protease complex with a phenylbenzoyl (S,R)-N-decalin type inhibitor | homo-2-mer | 2×3BL; | ||||
Assess | ||||||
Structure of SARS coronavirus main protease in complex with the alpha-ketoamide (S)-N-benzyl-3-((S)… | homo-2-mer | 2×D03; 2×DMS; | ||||
Assess | ||||||
complex structure of SARS-CoV 3CL protease with TG-0205486 | homo-2-mer | 2×ZU5; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with an alpha, beta-unsaturated ethyl… | homo-2-mer | 2×G75; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main proteinase(3CLPRO) | homo-2-mer | |||||
Assess | ||||||
Complex structure of SARS-CoV 3C-like protease with TDT | homo-2-mer | 2×ZN; 2×TLD; | ||||
Assess | ||||||
A Mechanistic view of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3… | homo-2-mer | 2×GOL; | ||||
Assess | ||||||
Complex structure of SARS-CoV 3C-like protease with JMF1600 | homo-2-mer | 4×DMS; 2×DOZ; | ||||
Assess | ||||||
Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV… | homo-2-mer | 2×D3F; | ||||
Assess | ||||||
Complex structure of SARS-CoV 3C-like protease with PMA | homo-2-mer | 2×HG; 2×BNZ; | ||||
Assess | ||||||
Crystal structures of SARS coronavirus main peptidase inhibited by an aza-peptide epoxide in the sp… | homo-2-mer | 2×AZP; 2×EDO; 2×GOL; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with Ac-ESTLQ-H (cocrystallization) | homo-2-mer | 1×MRD; | ||||
Assess | ||||||
Crystal structure of SARS-CoV main protease with authentic N and C-termini in complex with a Michae… | homo-2-mer | |||||
Assess | ||||||
Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV… | homo-2-mer | 2×F3F; | ||||
Assess | ||||||
Crystal structures of the SARS-coronavirus main proteinase inactivated by benzotriazole compounds | homo-2-mer | 2×XP1; 2×MES; 2×SO4; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with an alpha, beta-unsaturated ethyl… | homo-2-mer | 2×G81; | ||||
Assess | ||||||
Crystal structure of SARS-CoV 3CLpro in complex with the non-covalent inhibitor WU-04 | homo-2-mer | 2×J7R; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with an alpha, beta-unsaturated ethyl… | homo-2-mer | 2×G83; | ||||
Assess | ||||||
Structure of SARS coronavirus main protease in complex with the alpha-ketoamide (S)-N-benzyl-3-((S)… | homo-2-mer | 2×8O5; | ||||
Assess | ||||||
Crystal structure of unbound SARS coronavirus main peptidase in the space group C2 | homo-2-mer | 4×CL; 2×EDO; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with an alpha,beta-unsaturated ethyl … | homo-2-mer | 2×DMS; 2×G82; | ||||
Assess | ||||||
A Mechanistic view of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3… | homo-2-mer | 2×GOL; | ||||
Assess | ||||||
Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV… | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS-CoV main protease triple mutant STI/A in space group C2 | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS-COV main protease Asn214Ala mutant with authorize N-terminus | homo-2-mer | |||||
Assess | ||||||
A Mechanistic view of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3… | homo-2-mer | 4×GOL; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with Ac-DSFDQ-H (soaking) | homo-2-mer | |||||
Assess | ||||||
Structure of SARS-3CL protease complex with a Bromobenzoyl (S,R)-N-decalin type inhibitor | homo-2-mer | 2×3A7; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with Ac-NSTSQ-H (soaking) | homo-2-mer | 2×DMS; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with Ac-ESTLQ-H (Soaking) | homo-2-mer | 2×MES; | ||||
Assess | ||||||
SARS-CoV main protease triple mutant STI/A with two N-terminal additional residue (Gly-Ser) | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS 3CLpro C145A mutant | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS coronavirus main peptidase at pH 6.0 in the space group P21 | homo-2-mer | 1×MES; | ||||
Assess | ||||||
Crystal Structure Of SARS_CoV Mpro in Complex with an Inhibitor N9 | homo-2-mer | 2×9IN; | ||||
Assess | ||||||
Crystal Structure Of SARS-CoV Mpro in Complex with an Inhibitor N1 | homo-2-mer | 2×I12; | ||||
Assess | ||||||
complex structure of SARS-CoV 3C-like protease with JMF1586 | homo-2-mer | 4×DMS; 2×DAZ; | ||||
Assess | ||||||
Crystal Structure Of SARS_CoV Mpro in Complex with an Inhibitor N3 | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS-CoV Mpro mutant in P21 at pH6.9 | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS-CoV main protease triple mutant STI/A in space group P21 | homo-2-mer | |||||
Assess | ||||||
Crystal structure of Severe Acute Respiratory Syndrome (SARS) 3C-like protease Asn214Ala mutant | homo-2-mer | |||||
Assess | ||||||
N-terminal finger stabilizes feline drug GC376 in coronavirus 3CL protease | homo-2-mer | 2×UED; 2×EDO; 6×CA; | ||||
Assess | ||||||
Complex structure of SARS-CoV 3C-like protease with EPDTC | homo-2-mer | 4×DMS; 2×DTZ; | ||||
Assess | ||||||
Crystal structures of SARS coronavirus main peptidase inhibited by an aza-peptide epoxide in space … | homo-2-mer | 2×AZP; | ||||
Assess | ||||||
Crystal structure of SARS Coronavirus Main Proteinase (3CLpro) | homo-2-mer | |||||
Assess | ||||||
N-terminal finger stabilizes feline drug GC376 in coronavirus 3CL protease | homo-2-mer | 4×EDO; 2×UED; | ||||
Assess | ||||||
Crystal structure of SARS Coronavirus Main Proteinase (3CLpro) At pH7.6 | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS Coronavirus Main Proteinase (3CLpro) Complexed With An Inhibitor | homo-2-mer | |||||
Assess | ||||||
Crystal Structure Of SARS-CoV Mpro in Complex with an Inhibitor I2 | homo-2-mer | 2×ENB; | ||||
Assess | ||||||
X-ray structural analysis of SARS coronavirus 3CL proteinase in complex with designed anti-viral in… | homo-2-mer | 2×CY6; | ||||
Assess | ||||||
Structure Of Sars Cov Main Proteinase At 1.9 A (Ph6.5) | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS Coronavirus Main Proteinase (3CLpro) At pH8.0 | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS-CoV main protease quadruple mutant STIF/A with two molecules in one asymm… | homo-2-mer | |||||
Assess | ||||||
Substrate Specificity Profiling and Identification of a New Class of Inhibitor for the Major Protea… | homo-2-mer | 2×WR1; | ||||
Assess | ||||||
Crystal structure of SARS-CoV main protease quadruple mutant STIF/A with one molecule in one asymme… | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease complexed with Ac-NSFSQ-H (soaking) | homo-2-mer | |||||
Assess | ||||||
Structure-based Design and Synthesis and Biological Evaluation of Peptidomimetic SARS-3CLpro Inhibi… | homo-2-mer | 2×CYV; | ||||
Assess | ||||||
Crystal Structure of SARS Coronavirus Main Proteinase (P43212) | homo-2-mer | |||||
Assess | ||||||
A Structural View of the Inactivation of the SARS-Coronavirus Main Proteinase by Benzotriazole Este… | homo-2-mer | 3×DMS; 1×BEZ; 1×XP1; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main peptidase (with an additional Ala at the N-terminus of e… | homo-2-mer | 2×AZP; 2×ACY; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease in complex with PF07321332 | homo-2-mer | 2×4WI; | ||||
Assess | ||||||
Development of Broad-Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro | homo-2-mer | 2×959; | ||||
Assess | ||||||
Crystal structure of SARS main protease in complex with S217622 | homo-2-mer | 2×7YY; | ||||
Assess | ||||||
Crystal structure of SARS 3C-like protease in apo form | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS coronavirus main peptidase (with an additional Ala at the N-terminus of e… | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS coronavirus main protease in complex with Baicalei | homo-2-mer | 1×3WL; | ||||
Assess | ||||||
Crystal Structure of SARS Coronavirus Main Proteinase (P21212) | homo-2-mer | |||||
Assess | ||||||
human SARS coronavirus unique domain (triclinic form) | homo-2-mer | |||||
Assess | ||||||
Nsp9 protein from SARS-coronavirus. | homo-2-mer | |||||
Assess | ||||||
Crystal structure of SARS coronavirus NSP9 | homo-2-mer | 4×SO4; | ||||
Assess | ||||||
A Special Dimerization of SARS-CoV Main Protease C-Terminal Domain Due to Domain-swapping | homo-2-mer | |||||
Assess | ||||||
Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon AT… | monomer | 3×ZN; | ||||
Assess | ||||||
Crystal Structure of C-terminus of the non-structural protein 2 from SARS coronavirus | monomer | 2×ZN; | ||||
Assess | ||||||
SARS coronavirus papain-like protease: structure of a viral deubiquitinating enzyme | monomer | 1×ZN; 3×BR; 1×SO4; | ||||
Assess | ||||||
Crystal structure of the SARS CoV-1 Papain-like protease in complex with peptide inhibitor VIR251 | monomer | 1×ZN; 12×EDO; 2×SO4; | ||||
Assess | ||||||
Crystal structure of the SARS CoV-1 Papain-like protease in complex with peptide inhibitor VIR250 | monomer | |||||
Assess | ||||||
Crystal structure of SARS-CoV main protease with authentic N and C-termini | monomer | |||||
Assess | ||||||
Structure of SARS-3CL protease complex with a phenyl-beta-alanyl (R,S)-N-decalin type inhibitor | monomer | 1×SLH; | ||||
Assess | ||||||
Crystal Structure of a monomeric form of Severe Acute Respiratory Syndrome (SARS) 3C-like protease … | monomer | |||||
Assess | ||||||
Structure of SARS-3CL protease complex with a phenylbenzoyl (R,S)-N-decalin type inhibitor | monomer | 1×3X5; | ||||
Assess | ||||||
Crystal structure of SARS coronavirus 3CL protease inhibitor complex | monomer | 1×NOL; | ||||
Assess | ||||||
Complex structure of SARS-CoV 3CL protease with TG-0204998 | monomer | 1×ZU3; | ||||
Assess | ||||||
The co-crystal structure of SARS-CoV 3C Like Protease with aldehyde inhibitor M7 | monomer | 1×EJF; | ||||
Assess | ||||||
SARS-CoV main protease monomeric Arg298Ala mutant with N-terminal additional residues (Gly-Ser) | monomer | |||||
Assess | ||||||
Crystal structure of native SARS CLpro | monomer | |||||
Assess | ||||||
Structure of SARS-3CL protease complex with a phenyl-beta-alanyl (S,R)-N-decalin type inhibitor | monomer | 1×SDJ; | ||||
Assess | ||||||
Crystal structure of G11A mutant of SARS-CoV 3C-like protease | monomer | |||||
Assess | ||||||
Crystal Structure of N-terminus of the non-structural protein 2 from SARS coronavirus | monomer | 3×ZN; | ||||
Assess | ||||||
Crystal Structure of SARS-Unique Domain (SUD) of Nsp3 from SARS coronavirus | monomer | 9×CL; 5×SO4; | ||||
Assess | ||||||
Crystal Structure of L516C/Y647C Mutant of SARS-Unique Domain (SUD) from SARS-CoV-2 | monomer | 1×FMT; 1×ACT; 7×SO4; | ||||
Assess | ||||||
SARS-CoV Macro domain complexed with 3-(N-morpholino)propanesulfonic acid | monomer | |||||
Assess | ||||||
Crystal structure of SARS macro domain in complex with ADP-ribose at 1.8 A resolution | monomer | |||||
Assess | ||||||
NMR STRUCTURE OF SARS-COV NON-STRUCTURAL PROTEIN NSP3A (SARS1) FROM SARS CORONAVIRUS | monomer | 2×GOL; | ||||
Assess | ||||||
NMR structure of the domain 513-651 of the SARS-CoV nonstructural protein nsp3 | monomer | |||||
Assess | ||||||
NMR Conformer closest to the mean coordinates of the domain 513-651 of the SARS-CoV nonstructural p… | monomer | |||||
Assess | ||||||
NMR structure of the domain 527-651 of the SARS-CoV nonstructural protein nsp3, single conformer cl… | monomer | |||||
Assess | ||||||
NMR structure of the domain 527-651 of the SARS-CoV nonstructural protein nsp3 | monomer | |||||
Assess | ||||||
solution structure of C-terminal domain of SARS-CoV main protease | monomer | |||||
Assess | ||||||
NMR Structure of the nonstructural protein 1 (nsp1) from the SARS coronavirus | monomer | |||||
Assess | ||||||
NMR Structure of the nonstructural protein 1 (nsp1) from the SARS coronavirus | monomer | |||||
Assess | ||||||
NMR Structure of the SARS-CoV non-structural protein nsp3a | monomer | |||||
Assess | ||||||
NMR Structure of the SARS-CoV non-structural protein nsp3a | monomer | |||||
Assess | ||||||
NMR Structure of the nonstructural Protein 7 (nsP7) from the SARS CoronaVirus | monomer | |||||
Assess |
9 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7dte.1.A | monomer | 0.77 | 2×ZN; | 96.35 | ||
Assess | ||||||
7fac.1.A | monomer | 0.76 | 2×ZN; | 100.00 | ||
Assess | ||||||
6nur.1.A | monomer | 0.76 | 2×ZN; | 100.00 | ||
Assess | ||||||
7kf4.1.D | monomer | 0.74 | 88.73 | |||
Assess | ||||||
7msw.1.A | monomer | 0.73 | 2×ZN; | 68.34 | ||
Assess | ||||||
7n0d.1.D | monomer | 0.70 | 3×ZN; 1×MG; | 94.86 | ||
Assess | ||||||
7r2v.1.A | monomer | 0.68 | 1×SAH; 4×ZN; | 94.47 | ||
Assess | ||||||
6jyt.1.A | monomer | 0.65 | 3×ZN; | 100.00 | ||
Assess | ||||||
5wwp.2.A | monomer | 0.63 | 3×ZN; | 72.20 | ||
Assess |